|
| Thursday, January 23, 2020 |
|
|
疫情牽動人心，預防為主 |
| 近日，全國人民的注意力都被一種快速傳播的疾病─新型冠狀病毒感染的肺炎牽制，受該病毒感染的患者一般會出現發熱、乏力、乾咳、逐漸出現呼吸困難，嚴重者出現急性呼吸窘迫綜合症、膿毒症休克、難以糾正的代謝性酸中毒、出現凝血功能障礙、甚至死亡。 more info >> |
|
| Tuesday, August 27, 2019 |
|
|
金活25周年稳步前进 逐健康追梦征程 |
中国领先及全球知名大健康产品服务的全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）公布截至2019年6月30日止六个月（「回顾期」）未经审核之中期业绩。
more info >> |
|
|
金活25週年穩步前進 逐健康追夢征程 |
中國領先及全球知名大健康產品服務的全渠道供應鏈企業 - 金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）公佈截至2019年6月30日止六個月（「回顧期」）未經審核之中期業績。
more info >> |
|
|
Steady Development in Kingworld 25th Anniversary and Deepening Management New Journey in Pursuit of Quality and Healthy Living |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a leading global well-known omni-channel enterprise offering a complete supply chain spanning the greater health products and services industry, has announced its unaudited interim results for the six months ended 30 June 2019 (the "Period").
more info >> |
|
| Thursday, March 28, 2019 |
|
|
金活医药强化销售策略与渠道覆盖 引进新产品优化结构 念慈菴枇杷膏销售大幅增长25.6% |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）公布截至2018年12月31日止年度（「回顾年度」）经审核之全年业绩。
more info >> |
|
|
金活醫藥強化銷售策略與渠道覆蓋 引進新產品優化結構 念慈菴枇杷膏銷售大幅增長25.6% |
中國領先及全球知名大健康產品服務的全鏈條全渠道供應鏈企業 - 金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）公佈截至2018年12月31日止年度（「回顧年度」）經審核之全年業績。
more info >> |
|
|
Kingworld Medicines Strengthening Sales Strategy and Channel Coverage; Optimizing Structure by Introducing New Products; Sales of Nin Jiom Significantly Increased by 25.6% |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise with a complete supply chain in the greater health products and services industry in China, has announced its audited annual results for the year ended 31 December 2018 (the "Year Under Review").
more info >> |
|
| Wednesday, August 29, 2018 |
|
|
金活医药2018年上半年收益稳步提升，同比增长9.3%；本公司拥有人应占溢利上升24.4%至人民币2,755万元 |
中国领先及全球知名大健康产品服务的全链条全渠道供应链企业 - 金活医药集团有限公司（「金活医药」或「集团」，股份代号：01110.HK）欣然公布截至2018年6月30日止六个月（「回顾期」）未经审核之中期业绩。
more info >> |
|
|
金活醫藥2018年上半年收益穩步提升，同比增長9.3%；本公司擁有人應佔溢利上升24.4%至人民幣2,755萬元 |
中國領先及全球知名大健康產品服務的全鏈條全渠道供應鏈企業 - 金活醫藥集團有限公司（「金活醫藥」或「集團」，股份代號：01110.HK）欣然公佈截至2018年6月30日止六個月（「回顧期」）未經審核之中期業績。
more info >> |
|
|
Kingworld Medicines' 20181H Revenue Improved Steadily by 9.3%; Profit Attributable to Owners of the Company Increased 24.4% to RMB27.55 Million |
Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Group", stock code: 01110.HK), a globally leading and well-known omni-channel enterprise offering a complete supply chain spanning the greater health products and services industry, has announced its unaudited interim results for the six months ended 30 June 2018 (the "Period").
more info >> |
|
|
|
|
